Wednesday, July 8, 2026

Patent intelligence · US

US 7270994

Lactobacillus casei Bd-II stain and used to reduce blood cholesterol

granted A61KA61K38/00A61PA61P3/06
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 1
Applicant portfolio 57
Patent details — US 7270994

Quick answer

US 7270994 (Lactobacillus casei Bd-II stain and used to reduce blood cholesterol) is held by Shanghai Bright Dairy & Food Co. Ltd.. Status: granted. Granted Sep 18, 2007. Expires Sep 13, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
5
CPC classes
A61K, A61K38/00, A61P, A61P3/06

More from Shanghai Bright Dairy & Food Co. Ltd.

Related pharmaceutical patents in our USPTO index.

  1. US 12383631

    Immune antigen specific IL-18 immunocytokines and uses thereof

    Bright Peak Therapeutics AG · Expires Aug 7, 2045

    granted
  2. US 12350120

    Gum-protecting and teeth-whitening strip and preparation method thereof

    Jiangxi Dentalbright Technology Co., Ltd. · Expires Jul 3, 2045

    granted
  3. US 12220447

    Proteolytic enzyme composition

    Bright Lifecare PVT LTD. · Expires Feb 6, 2045

    granted
  4. US 12215133

    GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use

    BrightGene Bio-Medical Technology Co., Ltd. · Expires Jan 30, 2045

    granted
  5. US 12173062

    Modified TNF-α antibodies and uses thereof

    Bright Peak Therapeutics AG · Expires Dec 19, 2044

    granted
  6. US 12115136

    Fortified CBD oil for treatment of PTSD

    Bright Green Corporation · Expires Oct 10, 2044

    granted
  7. US 12097230

    Method and composition for treating post operative conditions

    Bright Green Corporation · Expires Sep 19, 2044

    granted
  8. US 11925686

    Materials for phototherapies of ophthalmic diseases

    EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. · Expires Mar 7, 2044

    granted

Frequently asked questions

What is US patent 7270994?

US 7270994 (Lactobacillus casei Bd-II stain and used to reduce blood cholesterol) is held by Shanghai Bright Dairy & Food Co. Ltd.. Status: granted. Granted Sep 18, 2007. Expires Sep 13, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.

Who owns US 7270994?

Shanghai Bright Dairy & Food Co. Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.

When does US 7270994 expire?

Our index shows an expiration date of Sep 13, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.